Robert Ross Carter net worth and biography

Robert Carter Biography and Net Worth

CFO of Oncology Institute

With over a decade of finance leadership experience in the healthcare sector, Mr. Carter is a seasoned executive dedicated to driving financial excellence and strategic growth. He joined The Oncology Institute in 2021 as Vice President of Finance and was promoted to Senior Vice President in 2023. In this role, he oversaw corporate finance, financial planning and analysis (FP&A), treasury and investor relations, playing a crucial role in shaping the organization’s financial strategy.

Rob is known for his ability to build high-performing teams and enhance financial and non-financial reporting processes, leveraging analytics to inform actionable business strategies. His extensive background spans various healthcare sectors, including pharmaceutical finance, Medicare Advantage, Medi-Cal, and physician group practices.

Before joining The Oncology Institute, Rob served as Head of FP&A at Hoag Health System, a multi-specialty physician group practice and management services organization (MSO). He also held several leadership positions in FP&A at SCAN Health Plan and McKesson US Pharma, where he honed his skills in financial management and strategic planning.

What is Robert Ross Carter's net worth?: The estimated net worth of Robert Ross Carter is at least $907.57 thousand as of January 2nd, 2026. Mr. Carter owns 235,122 shares of Oncology Institute stock worth more than $907,571 as of April 30th. This net worth approximation does not reflect any other investments that Mr. Carter may own. Learn More about Robert Ross Carter's net worth.
How do I contact Robert Ross Carter?: The corporate mailing address for Mr. Carter and other Oncology Institute executives is 345 PARK AVENUE SOUTH, NEW YORK NY, 10010. Oncology Institute can also be reached via phone at 562-735-3226 and via email at [email protected]. Learn More on Robert Ross Carter's contact information.
Has Robert Ross Carter been buying or selling shares of Oncology Institute?: Robert Ross Carter has not been actively trading shares of Oncology Institute in the last ninety days. Most recently, Robert Ross Carter sold 247 shares of the business's stock in a transaction on Friday, January 2nd. The shares were sold at an average price of $3.56, for a transaction totalling $879.32. Following the completion of the sale, the chief financial officer now directly owns 235,122 shares of the company's stock, valued at $837,034.32. Learn More on Robert Ross Carter's trading history.
Who are Oncology Institute's active insiders?: Oncology Institute's insider roster includes Robert Carter (CFO), Jorey Chernett (Major Shareholder), Brad Hively (Director), Mohit Kaushal (Director), Mark Pacala (Director), Yale Podnos (Director), and Daniel Virnich (CEO). Learn More on Oncology Institute's active insiders.
Are insiders buying or selling shares of Oncology Institute?: In the last year, Oncology Institute insiders bought shares 6 times. They purchased a total of 568,985 shares worth more than $1,759,600.65. In the last year, insiders at the sold shares 12 times. They sold a total of 11,585,436 shares worth more than $34,668,174.42. The most recent insider tranaction occured on April, 16th when Director Mohit Kaushal sold 38,433 shares worth more than $134,515.50. Insiders at Oncology Institute own 8.5% of the company. Learn More about insider trades at Oncology Institute.
Information on this page was last updated on 4/16/2026.

Robert Ross Carter Insider Trading History at Oncology Institute

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
1/2/2026	Sell	247	$3.56	$879.32	235,122

Robert Ross Carter Buying and Selling Activity at Oncology Institute

Oncology Institute Company Overview

The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services. The company also provides managing clinical trials, palliative care programs, stem cell transplants services, and other care delivery models associated with non-community-based academic and tertiary care settings; and conducts clinical trials for a range of pharmaceutical and medical device companies. It serves adult and senior cancer patients. The company has a strategic collaboration with Healthly Forge to offer cancer care services to patients in Southern California. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.

Today's Range

Now: $3.86

$3.66

$3.91

50 Day Range

MA: $3.10

$2.55

$3.71

2 Week Range

Now: $3.86

$2.02

$4.88

Volume

1,521,954 shs

Average Volume

1,898,432 shs

Market Capitalization

$381.52 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.17